Bin Huang, PhD, MBA
President and CEO, Emerald Health Therapeutics Inc.
Bin is an executive leader with over 30 years of experience in life sciences. Bin joined Emerald Health in December 2014. Her career began with Allelix Crop Technologies, where she spent six years as a plant research scientist. For a number of years, Bin was the President and CEO of Cytovax Biotechnologies, a Canadian biotechnology company. Following that, she led WEX Pharmaceuticals, a subsidiary of publicly listed CK Life Sciences International (Holdings) Inc., as President and CEO. Bin has a PhD in Plant Cell Biology from the University of East Anglia, UK and an MBA from the University of Toronto.